StockTipsArenaBeta

BUY Gland Pharma Limited — Rajesh Palviya, Axis Securities

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: 1 year25 Aug 2026via ET Now

Entry₹2,795.2Inferred
Target₹3,300
Total upside +18.06%
Stop lossNot given
CMP₹2,826.82d ago
Active+1.13%+16.74%upside left 10 mo left
Follow Rajesh Palviya for new callsGet alertsWatch GLAND for new buy/sell callsGet alertsSee 7 other Long-term calls on GLANDSee 274 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 9:35 pm IST
24 supporting10 neutral5 opposing
Supports the BUY call (24)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·23 Oct · 2d ago

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·13 Oct · 2w ago

5 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·7 Oct · 3w ago

Gland Pharma sets e-voting for Wang appointment; $21m US investment approved

NewsGoogle News·6 Oct · 3w ago

(opens in new tab)

Gland Pharma to invest $21 million in US drugmaker, take 60% stake

NewsCnbc-Tv18·1 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (10)

Q2 FY27 results scheduled — board meets 06 Nov 2026

BSE · Board Meeting·In 11 days

(opens in new tab)
Weighs against the BUY call (5)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·12 Aug · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Rajesh Palviya, Axis Securities

Every call and its outcome